Clinical Trial Update: Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection

View source ↗

Summary

A completed clinical trial evaluating zinc/PSA ratio as a biomarker for detecting prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Bagcilar Training and Research Hospital | Conditions: Prostate Cancer Detection | Status: COMPLETED | Results posted: 2019-04-16